Entera Bio initiated with an Outperform at Leerink
Strong Buy
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Strong Buy
What happened, with direct paths to the underlying reporting
ENTX received an Outperform target update from Leerink Partners. Target $9; Posted price $3.03; priceChangeSinceSignal +$1.32.
Target: $9
Posted price: $3.03
Analyst firm: Leerink Partners
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.